Cypress Capital Group Biogen Inc. Transaction History

Cypress Capital Group

$879 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$256.56 - $292.34 $25,656 - $29,233	100 Added 11.12%	999 $277,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $226,943 - $275,741	899 New	899 $248,000
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $198,840 - $255,539	-888 Closed	0 $0
Q3 2021 Oct 12, 2021	SELL	$282.99 - $369.05 $691,627 - $901,958	-2,444 Reduced 73.35%	888 $251,000
Q2 2021 Jul 13, 2021	SELL	$259.0 - $414.71 $196,063 - $313,935	-757 Reduced 18.51%	3,332 $1.15 Million
Q1 2021 Apr 14, 2021	BUY	$242.95 - $284.63 $133,136 - $155,977	548 Added 15.48%	4,089 $1.14 Million
Q4 2020 Jan 12, 2021	SELL	$236.26 - $355.63 $213,579 - $321,489	-904 Reduced 20.34%	3,541 $867,000
Q3 2020 Oct 08, 2020	BUY	$264.77 - $305.71 $26,741 - $30,876	101 Added 2.33%	4,445 $1.26 Million
Q2 2020 Jul 10, 2020	BUY	$258.66 - $342.55 $702,779 - $930,708	2,717 Added 166.99%	4,344 $1.16 Million
Q1 2020 Apr 08, 2020	BUY	$268.85 - $341.04 $13,711 - $17,393	51 Added 3.24%	1,627 $514,000
Q4 2019 Jan 10, 2020	SELL	$220.06 - $304.07 $74,160 - $102,471	-337 Reduced 17.62%	1,576 $468,000
Q3 2019 Oct 10, 2019	BUY	$217.44 - $243.88 $93,934 - $105,356	432 Added 29.17%	1,913 $446,000
Q2 2019 Aug 15, 2019	SELL	$219.29 - $241.72 $217,097 - $239,302	-990 Reduced 40.06%	1,481 $347,000
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $38,791 - $60,673	-179 Reduced 6.75%	2,471 $584,000
Q4 2018 Feb 19, 2019	BUY	$278.5 - $352.75 $123,932 - $156,973	445 Added 20.18%	2,650 $797,000
Q3 2018 Nov 15, 2018	BUY	$293.51 - $383.83 $99,793 - $130,502	340 Added 18.23%	2,205 $779,000
Q2 2018 Aug 15, 2018	BUY	$257.52 - $306.91 $27,039 - $32,225	105 Added 5.97%	1,865 $542,000
Q1 2018 May 21, 2018	BUY	$260.13 - $367.91 $82,981 - $117,363	319 Added 22.14%	1,760 $482,000
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $10,152 - $11,371	33 Added 2.34%	1,441 $459,000
Q3 2017 Nov 16, 2017	BUY	$281.15 - $329.69 $179,654 - $210,671	639 Added 83.09%	1,408 $441,000
Q2 2017 Aug 15, 2017	BUY	N/A	769	769 $209,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.44 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.39 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.13 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.08 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$752 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.

Account